UNDERWRITING AGREEMENTUnderwriting Agreement • February 7th, 2006 • Genitope Corp • Biological products, (no disgnostic substances) • California
Genitope Corporation, a Delaware corporation (the “Company”), proposes to issue and sell up to an aggregate of 6,400,000 shares of its authorized but unissued common stock, $0.001 par value per share (the “Common Stock”), to the Underwriters (as hereinafter defined), for whom you (the “Representatives”) are acting as representatives (said 6,400,000 shares of Common Stock to be issued and sold by the Company being herein called the “Underwritten Stock”). The Company has also granted the Underwriters an option to purchase up to an aggregate of 960,000 additional shares of Common Stock (the “Option Stock,” and the Option Stock together with the Underwritten Stock being hereinafter referred to as the “Shares”). The Common Stock is more fully described in the Registration Statement and the Prospectus hereinafter mentioned.
